UnitedHealth Group Sees Unusually High Options Volume (UNH)
UnitedHealth Group Incorporated (NYSE:UNH) was the recipient of unusually large options trading activity on Friday. Stock traders acquired 5,895 put options on the company. This is an increase of approximately 254% compared to the typical volume of 1,667 put options.
In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of the business’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the transaction, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the transaction, the director now directly owns 60,834 shares of the company’s stock, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. In the last three months, insiders have sold 76,174 shares of company stock valued at $14,981,909. Company insiders own 0.89% of the company’s stock.
Several institutional investors have recently made changes to their positions in UNH. Patriot Financial Group Insurance Agency LLC grew its holdings in shares of UnitedHealth Group by 1,722.9% during the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after purchasing an additional 603 shares during the last quarter. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at approximately $110,000. Kings Point Capital Management grew its holdings in shares of UnitedHealth Group by 27.9% during the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after purchasing an additional 150 shares during the last quarter. Bruderman Asset Management LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at approximately $114,000. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. grew its holdings in shares of UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors.
Shares of UnitedHealth Group (UNH) opened at 193.03 on Monday. The firm’s 50-day moving average is $195.56 and its 200 day moving average is $181.26. The company has a market capitalization of $186.63 billion, a PE ratio of 23.19 and a beta of 0.63. UnitedHealth Group has a 52 week low of $133.03 and a 52 week high of $200.76.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, beating the consensus estimate of $2.38 by $0.08. The company had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period in the previous year, the company earned $1.96 EPS. On average, analysts anticipate that UnitedHealth Group will post $9.87 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th were given a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.55%. The ex-dividend date of this dividend was Thursday, September 7th. UnitedHealth Group’s payout ratio is presently 35.13%.
A number of brokerages have recently commented on UNH. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective for the company in a research report on Thursday. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Cantor Fitzgerald reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Tuesday, August 29th. UBS AG reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a $215.00 price objective on shares of UnitedHealth Group in a research report on Friday, August 18th. One equities research analyst has rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $203.59.
COPYRIGHT VIOLATION WARNING: This article was first published by Watch List News and is the sole property of of Watch List News. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://www.watchlistnews.com/unitedhealth-group-sees-unusually-high-options-volume-unh/1586641.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.